Press release
Carcinoembryonic Antigen (CEA) Market- Forecast to 2027
Market IntroductionCEA stands for Carcinoembryonic antigen. CEA is a form of glycoprotein molecule that is generated by cells of the gastrointestinal tract during embryonic development. It is produced in very small quantity after birth. The level of CEA in the bloodstream is thus relatively low unless certain diseases - including certain forms of cancer - are present. Carcinoembryonic antigen (CEA) portrays an arrangement of highly related glycoproteins involved in cell attachment. CEA is normally present just at low levels in the blood of healthy adults. In any case, If the serum levels are brought up in some type of cancer, which implies that it can be used as a tumor maker in clinical tests. Serum levels can likewise be raised in overwhelming smokers. CEA are glycosyl phosphatidyl inositol (GPI) cell surface anchored glycoproteins whose specific sialofucosylated glycoforms serve as functional colon carcinoma L-selectin and E-selectin ligands, which may be important to the metastatic dissemination of colon carcinoma cells. Immunologically they are portrayed as individuals from the CD66 cluster of differentiation
A normal level of CEA is equal to or less than 3 nanograms per milliliter (ng/mL). Most healthy adults have levels below this amount. CEA levels will generally return to normal between one and four months after cancer has been successfully removed from a patients system
The common reasons other than cancer for the growth of Carcinoembryonic antigen CEA are
• Cirrhosis of the liver
• Inflammatory bowel disease
Request a Sample@ https://www.marketresearchfuture.com/sample_request/772
• Heavy smoking
• Infection
Carcinoembryonic Antigen (CEA) test Application
A CEA test is most useful if you’ve been diagnosed with a type of cancer, which is known to produce CEA. Not all types of cancers produce CEA. Increased levels of CEA may be found in the following cancers:
• breast cancer
• lung cancer
• prostate cancer
• liver cancer
• colorectal cancer
• pancreatic cancer
• Thyroid cancer
• Others
Major Market Players:
• Roche Diagnostics
• Quest Diagnostics
• Correlogic Systems
• Inc., GenWay Biotech Inc
Market growth driver:
With the diagnosis of different types of cancers in the globe, Carcinoembryonic Antigen (CEA) test helps the doctor to diagnose and find out the type of cancer present in the patient’s body. With this unique quality CEA tests demand and market will be in huge demand and this market will be highly lucrative.
Regional Analysis:
North America
Carcinoembryonic Antigen (CEA) market for North America is one of the biggest markets in the globe the main reason behind this is the Cancer rate in the North American countries. Cancer usually develops in older people 86% of all cancers in the United States are diagnosed in people 50 years of age or older.
Typical behaviors also increase the risk of being diagnosed by cancer, these include eating unhealthy diet, heavy smocking or not being physically active. According to cancer facts and figures 2016 US, in a life time the probable risk of developing cancer in men in 42%, one in two men and for women it is 38% that is one in three women. It is estimated that 16,85,210 new cancer case are found in the US every year out of which 5,95,690 have ended up in deaths. With the rate of growth cancer is facing it can easily be estimated that the amount of test taken to diagnose cancer will increase, out of which one test is Carcinoembryonic Antigen (CEA) test. Hence this market will gain huge demand and is expect to grow at a very high growth rate
Access to report@https://www.marketresearchfuture.com/reports/carcinoembryonic-antigen-market
Europe
Europe is the second largest market for Carcinoembryonic Antigen (CEA). This is also because the high growth rate of cancer in Europe. Most cancers are related to lifestyle, behavioral or environmental exposures. The term environmental is used by cancer experts because it refers to everything outside the body that is being interacted with humans. in this sense, the environment is not limited to the biophysical environment(pollution, air, sunlight etc) it also includes lifestyle behavior factors, common behavior factors that lead to cancer is tobacco, diet, obesity, radiation, stress and environmental pollutions. As per FACE in 2009 all European countries had 2,333,407 number of new cancers cases and is expect to grow to 2,660,561 in 2020 with a percentage increase of 14.0. with this growth rate the market for Carcinoembryonic Antigen (CEA) tests will increase and it will face tremendous growth in the coming future.
The reports also covers brief analysis of Geographical Region includes:
Americas
• North America
• US
• Canada
• Mexico
• Latin America
Europe
• Western Europe
• Germany
• France
• Italy
• Spain
• U.K
• Rest of Western Europe
• Eastern Europe
Asia– Pacific
• Asia
• China
• India
• Japan
• South Korea
• Rest of Asia
• Pacific Countries
The Middle East& Africa
Every report of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report also gives a broad study of the different market segments and regions
Request a TOC@ https://www.marketresearchfuture.com/request-toc/772
About Market Research Future
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
About Market Research Future
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Carcinoembryonic Antigen (CEA) Market- Forecast to 2027 here
News-ID: 456849 • Views: …
More Releases from Market Research Future

9-Decanoic Acid Methyl Ester Market Poised for Strong 6.59% CAGR Growth Through …
The 9-decanoic acid methyl ester market is a growing sector driven by the increasing demand for bio-based and sustainable chemical products across various industries. With its unique properties, it finds application in flavors and fragrances, pharmaceuticals, personal care, and as a chemical intermediate. The market is projected to expand significantly in the coming years.
Market Overview and Size
The global 9-decanoic acid methyl ester market was valued at USD 230.0 million in…

Washable Marker Market Poised for 3.54% CAGR Growth During 2024-2032
The washable marker market is a dynamic and growing segment within the broader stationery and art supplies industry. Driven by a blend of consumer demands for safety, convenience, and sustainability, the market is experiencing consistent expansion, particularly within the education and home-use sectors. While faced with some challenges, the industry's future looks promising, propelled by product innovation and evolving consumer trends.
Get Sample @ https://www.marketresearchfuture.com/sample_request/41217
Market Size and Growth
The global washable…

Phone Car Mounts Market to Reach USD 7.37 Billion by 2034, Growing at 6.47% CAGR
The phone car mounts market, a critical sub-segment of the broader automotive accessories industry, is experiencing robust growth driven by a convergence of technological advancements, evolving consumer behavior, and increasingly stringent road safety regulations. As smartphones become indispensable for navigation, communication, and in-car entertainment, the demand for secure and convenient hands-free solutions continues to escalate. The global phone car mounts market was valued at USD 3.93 billion in 2024 and…

Intravenous (IV) Solution Market Set to Grow to USD 26.60 Billion at 7.70% CAGR …
Market Overview:
The Intravenous (IV) Solution Market is estimated to be valued at USD 13.9 billion in 2023 and is projected to reach USD 26.60 billion by 2032, expanding at a compound annual growth rate (CAGR) of 7.70% from 2024 to 2031. The market growth is attributed to the rising prevalence of chronic diseases, growing hospitalization rates, and increasing surgical procedures that require IV fluid administration. Intravenous solutions are critical…
More Releases for CEA
CEA ELISA Kits Market Outlook and Future Projections for 2030
The cea elisa kits market represents a dynamic and continually evolving landscape, shaped by changing consumer demands and technological advancements. In this comprehensive report, we provide an in-depth exploration of the market, designed for a wide range of stakeholders including manufacturers, suppliers, distributors, and investors. Our goal is to equip industry participants with essential insights that enable informed decision-making in an ever-changing market environment. This analysis not only examines the…
Carcinoembryonic Antigen (CEA) Market Size, Share | Industry Report 2026
The global Carcinoembryonic Antigen (CEA) Market was valued at $5.3 Billion in 2018 and is forecast to grow at a modest 6.1 % CAGR between 2018 and 2026, culminating in 2026 global sales of $ 9.2 Billion.
Carcinoembryonic AntigenTest is a blood test which identifies the diagnose and manage certain cancer disease like rectum and large intestine. Basically, it is used to check how well treatment is working in certain…
Carcinoembryonic Antigen (CEA) Market Investment Research Report 2017 – 2027
Carcinoembryonic antigen (CEA) is normally found in embryonic entodermal epithelium. Carcinoembryonic antigen is a group of glycoprotein present in the body fluids of the fetus and embryo and in the gastrointestinal tract. Carcinoembryonic antigen is also present in the mucosal cells of the colorectum, gastrointestinal cells, and small amounts are present in the blood. Carcinoembryonic antigen is produced by the gastrointestinal tissues during the development of fetal. CEA is not…
Carcinoembryonic Antigen (CEA) Market foreseen to grow exponentially over 2027
Carcinoembryonic antigen (CEA) is normally found in embryonic entodermal epithelium. Carcinoembryonic antigen is a group of glycoprotein present in the body fluids of the fetus and embryo and in the gastrointestinal tract. Carcinoembryonic antigen is also present in the mucosal cells of the colorectum, gastrointestinal cells, and small amounts are present in the blood. Carcinoembryonic antigen is produced by the gastrointestinal tissues during the development of fetal. CEA is not…
Carcinoembryonic Antigen (CEA) Market to hit $2.7bn by 2023
Carcinoembryonic Antigen (CEA) Market size is driven by increasing incidence rate for cancer disease especially colorectal cancer is one of the important factor contributing to the growth. Global Carcinoembryonic Antigen Market is set to register profitable growth in the near future and surpass USD 2.8 billion by 2023.
This growth is attributed to factors including consistent technology advancements, development of novel biomarkers and growing prevalence of cancer. Global Market Insights,…
CEA Antibodies Market Outlook And Research Survey To 2023
CEA stands for carcinoembryonic antigen, is a protein that is usually produced in developing fetus and disappears or is absent in adults. Production of abnormal amount of CEA protein may lead to cancer. CEA test is performed to measure the level of proteins and check for the recurrence of colon and other cancers in patients already diagnosed with cancer. The normal accepted range of this protein that is non-cancerous in…